Agonist binding to the inhibitory glycine receptor (GlyR) initiates the opening of a chloride-selective channel that modulates the neuronal membrane potential. Point mutations of the GlyR, substituting Arg-271 with either Leu or Gin, have been shown to underlie the inherited neurological disorder startle disease (hyperekplexia). We show that these substitutions result in the redistribution of GlyR single-channel conductances to lower conductance levels. Additionally, the binding of the glycinergic agonists I$-alanine and taurine to mutated GlyRs does not initiate a chloride current, but instead competitively antagonizes currents activated by glycine. These findings are consistent with mutations of Arg-271 resulting in the uncoupling of the agonist binding process from the channel activation mechanism of the receptor.
Introduction
Fast synaptic neurotransmission in the mammalian nervous system is mediated by the ligand-gated ion channel (LGIC) class of neurotransmitter receptors, which includes the receptors for acetylcholine, serotonin, y-aminobutyric. acid, and glycine (Grenningloh et al., 1987; Schofield et al., 1987; Maricq et al., 1991) .
LGICs are composed of five subunits arranged in the postsynaptic membrane to form a central ion channel. Each subunit consists of a large, N-terminal extracellular domain and four transmembrahe domains (M1-M4). The agonist-binding sites and the ion channel of LGIC receptors are physically distinct (Unwin, 1993; Valenzuela et al., 1994) . In the glycine receptor (GlyR), the agonists glycine, 13-alanine, and taurine bind to sites in the N-terminal extracellular region (Kuhse et al., 1990; Vandenberg et al., 1992; Schmieden et al., 1992 Schmieden et al., , 1993 , thereby initiating the rapid opening of a chloride-selective channel formed by the transmembrane domains (Grenningloh et al., 1987) . Although the agonist binding and ion permeation processes of the GlyR and other LGIC receptors have been described in increasing detail (Sieghart, 1992; Vandenberg and Schofield, 1993; Devillers-Thiery et al., 1993) , little is known of the mechanism linking these two events.
Point mutations of the GlyR ~1 subunit have recently been shown to underlie the autosomal dominant neurological disorder startle disease, or hyperekplexia (Kirstein and Silfverskiold, 1958; Suhren et al., 1966; Andermann and Andermann, 1988; Shiang et al., 1993) . This disease results in muscular hypertonia and an exaggerated startle response to sensory stimuli (Kirstein and Silfverskiold, 1958; Suhren et al., 1966; Andermann and Andermann, 1988) . GlyR ~xl subunits containing startle disease point mutations substituting Leu or Gin for Arg-271 (Shiang et al., 1993) display dramatic 230-to 410-fold reductions in the glycine-activated current sensitivity (Rajendra et al., 1994) . The finding that Arg-271 is a highly specific determinant of glycine activation is unexpected because of its location at the extracellular border of the channel-lining M2 transmembrane domain rather than in the N-terminal extracellular region. We now show that mutation of Arg-271 transforms the glycinergic agonists 13-alanine and taurine into competitive antagonists. This transformation is consistent with the uncoupling of the agonist-binding and channel-opening events within the GlyR. Arg-271 is thus a critical element for the transduction of agonist binding into channel activation in at least one member of the LGIC class of neurotransmitter receptors.
Results
Site-directed mutagenesis was used to replace Arg-271 with either Leu (R271 L) or Gin (R271Q) in the human GlyR ~1 subunit cDNA (Grenningloh et al., 1990) . Transfection of the cDNA into human embryonic kidney 293 cells resulted in the expression of homomeric al subunit GlyRs, which were subsequently examined using patch-clamp techniques (Hamill et al., 1981) and [3H]strychnine binding assays. Mutation of Arg-271 to Leu or Gin produced a 230-to 410-fold reduction in the sensitivities of glycineactivated currents (Rajendra et al., 1994) . Glycine was therefore used at 50 mM to elicit maximal currents in the mutant GlyRs, and at 1 mM in the wild-type (WT) GlyRs ( Figure 1A ). Both the rate and extent of decay of maximal currents were reduced in the mutant GlyRs as compared with WT GlyRs (Figure 1A) , and the magnitudes of maximal glycine-activated currents were also considerably smaller ( Figure 1B) . The extent of current decay was inversely correlated to current size in WT GlyRs (Pearson correlation, n = 10, r ---0.78, p --0.008). For currents elicited by 1 mM glycine, the ratio of the current size at 10 s to the current size at 1 s was 0.84 when the peak current was 0.4 nA, but only 0.34 for an 8.0 nA peak current. The size and extent of decay of currents were not strongly correlated in either R271L GlyRs (Pearson correlation, n = 8, r --0.22, p = 0.59) or R271Q GlyRs (Pearson correlation, n = 8, r = -0.39, p = 0.34). Thus, the reduced current decay in the mutant GlyRs may be attributed largely to the absence or diminishment of a chloride shift effect (Akaike et al., 1987; Cascio et al., 1993) .
The decreased current sizes in cells expressing the mu- tant GlyRs were not caused by a reduction in the numbers of expressed receptors (Br, ax). Indeed, the mutant GlyRs showed up to 3-fold higher receptor numbers per cell than WT GlyRs (Rajendra et al., 1994 ) ( Figure 1C ). This suggests that the relative decrease in current through the mutant GlyRs is even more pronounced at the single-channel level ( Figure 1D ). Single-channel measurements were made from outside-out patches to ascertain whether the reduction was due to changes in the single-channel conductance. At a holding potential of -55 mV, application of 0.1-10 I~M glycine to WT GlyRs or 0.1-10 mM glycine to the mutant GlyRs elicited single-channel currents that reversed direction close to 0 mV, the expected equilibrium potential for chloride. In WT GlyRs, conductance states (and frequency of occurence) of 88 pS (51 O/o), 68 pS (36%), 49 pS (4%), and 30 pS (9%) were seen ( Figure 2A ). Their size and distribution correspond to those reported in previous studies demonstrating multiple conductance states in single (zl homomeric GlyR channels (Takahashi et al., 1992; Bormann et al., 1993) . However, the distributions of conductance states in mutant GlyRs were markedly different. In R271L GlyRs, conductance states of 63 pS (14%), 47 pS (33%), 29 pS (25%), and 16 pS (28%) were observed ( Figure 2B ). R271Q GlyRs displayed only a single 18 pS conductance state ( Figure 2C ). Thus, reduced elementary conductances contribute significantly to the decreases in whole-cell, glycine-activated currents in cells expressing the mutant GlyRs. In WT GlyRs, application of 2 mM 13-alanine or 10 mM taurine was sufficient to elicit maximal currents ( Figure  1A ). However, application of either agonist at concentrations up to 100 mM failed to elicit any current flow in either of the m utant GlyRs ( Figure 1A ). To determ ine whether this abolition of current was due to the absence of 13-alanine or taurine binding to the mutant GlyRs, [3H]strychnine displacement assays were performed ( Figure 3 ). Whereas the apparent glycine binding affinities (Ki values) in the mutant GlyRs were reduced 50-to 100-fold with respect to the WT GlyR, the apparent binding affinities of 13-alanine and taurine were reduced only 4-to 12-fold (Table 1 ; Figure 3) . Consequently, 13-alanine and taurine bind to the mutant GlyRs with higher affinities than glycine (Table 1 The effects of I5-alanine and taurine binding on currents elicited by glycine binding to the mutant GlyRs were studied by simultaneously applying either 13-alanine or taurine with glycine. In WT GlyRs, coapplication of up to 100 mM 13-alanine or taurine did not alter the current elicited by 1 mM glycine ( Figure 4A ). In the mutant GlyRs, however, currents elicited by 50 mM glycine were reduced in a dosedependent manner upon coapplication of either 13-alanine or taurine and were virtually abolished upon coapplication of 100 mM 13-alanine or taurine (Figure 4 ). To determine whether this antagonism was competitive or noncompetitive, the dose-response curves of glycine-activated currents, obtained by application of glycine alone, were compared with those obtained upon coapplication of 1 mM I~-alanine or taurine ( Figure 5A ). For R271L and R271Q GlyRs, coapplication of 1 mM 13-alanine produced 3.3-to 3.5-fold increases in the ECso for glycine without affecting the values of maximal glycine-activated currents (Ira,x; Fig- 
Mean values and SEM from five independent determinations for glycine and three to four independent determinations for 13-alanine and taurine are shown. The values in parentheses are the -fold changes relative to the values for the WT GlyR.
ure 5A). Similarly, coapplication of taurine to R271L and R271Q GlyRs caused 3.1-to 3.6-fold increases in the ECs0 for glycine without altering Im~x ( Figure 5A ). These reductions in glycine sensitivity without an alteration in the size of maximal currents are characteristic of competitive antagonism. Application of 1 I~M strychnine or 100 I~M picrotoxin alone did not elicit currents from either R271L or R271Q GlyRs (n = 5), indicating that neither of these competitive antagonists of the GlyR had been converted to agonists. Indeed, these concentrations abolished to<10% maximal glycine-activated currents in both WT and mutant GlyRs (n = 5; data not shown). Thus, the mutations of Arg-271 transform agonists into competitive antagonists, but not competitive antagonists into agonists.
To determine whether the binding of 13-alanine or taurine to the mutant GlyRs resulted in the desensitization of the receptor, the recoveries of glycine-activated currents elicited subsequent to a conditioning application of either glycine, 13-alanine, or taurine were compared ( Figure 5B ). Glycine-activated currents elicited 5 s after a 20 s conditioning application of 100 mM glycine were 38% and 43% of the size of control currents elicited in the absence of a conditioning pulse for R271 L and R271Q GlyRs, respectively. This result demonstrates that a significant proportion of the mutant GlyRs remained in the desensitized state. In contrast, the size of currents elicited 5 s after a 20 s conditioning application of 100 mM 13-alanine or taurine did not differ substantially from those elicited in the absence of the conditioning application. Relative current sizes were 93% and 92% for 13-alanine and taurine, respectively, for R271L GlyRs, and 90% for both I~-alanine and taurine for R271Q GlyRs ( Figure 5B ). Hence, receptor desensitization caused by binding of I~-alanine and taurine does not underlie their antagonism of glycine-activated currents.
Discussion
In the GlyR and other LGICs, agonist binding initiates the transition of the receptor from a nonconducting (closed) state to a conducting (open) state. The prolonged presence of bound agonist produces a further transition to a nonconducting, desensitized state. The Hill coefficients for glycine-activated currents in both WT and mutated GlyRs are greater than 1 (Rajendra et al., 1994) , suggesting that at least two agonist molecules are required to activate the GlyRs. A minimal scheme describing the progression from agonist binding to channel activation and receptor desensitization is Rc *-~ ARc *-~ A2Rc *-* A2Ro ~ A2RD
where A is the agonist (A2 referring to two agonist molecules being bound), and Rc, Ro, and RD represent the receptor in closed, open, and desensitized states, respectively. Whereas this progression is completed by glycine in the mutant GlyRs, ~-alanine and taurine initiate step 1, and possibly step 2, but not step 3, which would elicit a current. Thus, the normal transition of the receptor from the closed to open state upon I~-alanine and taurine binding has been prevented by mutation of Arg-271. The competitive antagonism of glycine by 13-alanine and taurine arises from their competition for the single-and/or doubleagonist bound states arising from steps 1 and 2. The sizes of both whole-cell, glycine-activated currents (Figure 1 ) and single-channel conductances (Figure 2) were reduced in the mutant GlyRs. This finding is similar to that of a mutational study of analogous residues of nicotinic acetylcholine receptor (nAChR) subunits (Imoto et al., 1988) and is consistent with Arg-271's positive charge and location at the extracellular border of the receptor channel (Grenningloh et al., 1987; Langosch et al., 1991 Langosch et al., , 1993 . However, we found no obvious change in either the relative anion-cation selectivities or the shapes of currentvoltage relations of whole-cell currents through R271 L and R271Q GlyRs (Rajendra et al., 1994) . Also, it is unclear whether the redistribution of channel conductances to lower levels that we report here fully accounts for the diminishment of whole-cell currents, and it is possible that altered channel kinetics also contribute, The single-channel traces in Figure 2 (note longer time scale for [C] ) suggest that the mutant GlyRs may exhibit longer channel open times and channel bursting. These changes may explain the increased sustained component and reduced extent of decay of whole-cell currents through the mutant GlyRs ( Figure 1; Figure 4 ; Figure 5) .
The values of the three largest conductance states of R271L GlyRs correlate closely with the three smallest states ofWT GlyRs (Figure 2) . Furthermore, the 16 and 18 pS conductance states seen in R271 L and R271Q GlyRs, respectively, may correspond to an infrequent 18 pS state reported in al homomeric GlyRs . It is unlikely that the 63, 47, and 29 pS conductance states seen in R271L GlyRs are the summation of 2, 3, or 4 of the 16-18 pS conductances seen in both mutant GlyRs, since we frequently observed direct transitions of the closed state to or from one of these higher states ( Figure  2 ). The mutations of Arg-271 may therefore prevent or impair transitions of the channel to one or more conducting conformations. These transitions are collectively represented by step 3 in the scheme above, the same step that is abolished for I~-alanine and taurine in themutant GlyRs.
The redistribution of glycine-activated conductances to lower levels in the mutant GlyRs may thus be an intermediate manifestation of the same mechanism that prevents channel activation by ~-alanine and taurine. However, the reductions in the apparent binding affinity for glycine were an order of magnitude or more higher than the 4-to 12-fold reductions for I~-alanine and taurine (Rajendra et al., 1994) (Table 1; Figure 3) , suggesting that mutations of Arg-271 may have impaired the binding site for glycine but not 13-alanine or taurine. The different effects exerted by these mutations on glycine as compared with ~-alanine or taurine may be due to the noncongruence of the binding sites for these competitive agonists (Kuhse et al., 1990; Vandenberg et al., 1992; Schmieden et al., 1992 Schmieden et al., , 1993 . After submission of this manuscript, Langosch et al. (1994) reported on a study of the same mutations of Arg-271. Their report, which confirms our earlier finding that these mutations reduce the glycine sensitivity of the GlyR (Rajendra et al., 1994) , describes similar changes in glycine-activated single-channel conductances.
By uncoupling the event of agonist binding from that of channel opening, the startle disease mutations have identified Arg-271 as a critical element of the signal transduction mechanism of the GlyR. Cysteine residues affecting channel gating have been identified in the M1 and M4 regions of nAChR subunits (Lo et al., 1991; Li et al., 1992; Lee et al., 1994) . In contrast to our findings, mutation of these residues increases macroscopic currents, as would be consistent with an impairment of the channel-closing mechanism (Lo et al., 1991; Li et al., 1992; Lee et al., 1994) . In the nAChR, mutations of located in an agonist-binding domain in the N-terminal extracellular region of the a subunit (Tomaselli et al., 1991) , transform partial agonists into antagonists (O'Leary and White, 1992) . That the alteration of an agonist-binding domain impairs channel gating is not unexpected owing to the reciprocity of these two processes (Amin and Weiss, 1993; Colquhoun and Farrant, 1993) . A similar explanation does not easily account for the effects arising from mutation of Arg-271, since, as reasoned earlier, this residue does not appear to be directly involved in 13-alanine or taurine binding. Mutation of a leucine residue in the nAChR channel region achieves the converse effect of transforming competitive antagonists into agonists by converting a high affinity, nonconducting, desensitized state into a conducting state (Bertrand et al., 1992) . It is unlikely that a similar mechanism underlies the effects we report, since the binding of 13-alanine or taurine does not cause desensitization in the mutant GlyRs ( Figure 5C ). Also, application of the competitive glycinergic antagonists picrotoxin (Lynch et al., unpublised data) and strychnine did not induce currents. The decay of whole-cell, glycine-activated currents is altered in the mutant GlyRs ( Figure 1; Figure 4 ; Figure 5 ). Diminished chloride shift effects (Akaike et al., 1987; Cascio et al., 1993) appear to be responsible, at least in part, since WT GlyR currents of sizes comparable to those of mutant GlyRs also show a similarly reduced decay (see Figure 1 in Rajendra et al., 1994) . Nevertheless, altered desensitization kinetics in the mutant GlyRs may also contribute.
That the distinction between agonism and antagonism resides in the nature of a single residue provides an important clue as to the mechanisms of action of these two classes of ligands. The simplest explanation is that Arg-271 is crucial for the integration of information from agonist-and antagonist-binding sites and the subsequent transmission of an appropriate signal to the activation gate of the channel.
Experimental Procedures

Site-Directed Mutagenesis
The cDNA encoding the (~1 subunit of the human glycine receptor (Grenningloh et al., 1990) was subcloned into the pCIS expression vector (Gorman et al., 1990) . Mutations in the cDNA were constructed using the oligonucleotide-directed polymerase chain reaction mutagenesis method of Ho et al. (1989) and were confirmed by sequencing the cDNA clones.
Expression of Mutated GlyR el Subunit cDNAs
Plasmid DNA encoding WT or mutated ~1 subunits of the human glycine receptor was transfected using the method of Chen and Okayarea (1987) into exponentially growing 293 cells (adenovirus transformed human embryonic kidney cells; ATCC CRL 1573; Sontheimer et al., 1989; Gorman et al., 1990) . After 24 hr, the cells were washed twice with culture medium (Eagle's minimum essential medium in Hanks salts supplemented with 2 mM glutamine and 10% fetal calf serum) and refed. Intact cells were used for electrophysiologicsl examination or harvested 48 hr after transfection for [3H]strychnine binding assays.
Electrophysiological Measurements
Following transfetion (48 hr), cells were patch clamped in the whole-cell mode or outside-out, excised-patch configuration (Hamill et al,, 1981 ) at a holding potential of -55 mV while being continually superfused with a bath solution containing 140 mM NaCI, 10 mM glucose, 5 mM KCI, 2 mM CaCI2, 2 mM MgCI2, and 10 mM HEPES (pH 7.4). Glycine, ~-alanine, or tauri ne dissolved in th is solution was rapidly applied to the chamber using a microperfusion tube system. No significant osmotic effects were observed, even at 100 mM agonist concentrations (Figures 1A; Figure 5 ). Voltages were corrected for junction potentials using the JPCalc program (Barry, 1994) . The pipette solution contained 145 rnM CsCI, 2 mM CaCI2, 2 mM MgCI2, 10 mM HEPES, and 10 mM EGTA (pH 7.4). Dose-response data for glycine-activated currents in individual cells were fitted using a nonlinear least squares algorithm to the Hill equation: I/1~,~ = [G]h/(ECso" + [G]h), where I is the magnitude of the peak current elicited by a concentration [G] of glycine, Im~ is the magnitude of the maximum peak current elicited by saturating concentrations of glycine, ECso is the value of [G] required to elicit a half-maximal peak current, and h is the Hill coefficient. Currents from outside-out patches were stored digitally at a sampling rate of 4 kHz and filtered at 1 kHz before analysis using pCLAMP software (Axon Instruments, Foster City, CA).
[3H]Strychnine Binding Assays Transfected cells were incubated with [3H]strychnine (1-50 nM; 24.5 Ci/mM; New England Nuclear) with or without 10 pM cold strychnine to determine nonspecific binding. After incubation to equilibrium at 4°C for 60 min, cells were collected by rapid filtration onto Whatrnan GF/B filter paper, and the amount of radioactive strychnine remaining bound was determined. The I~ and Bm~ for the [3H]strychnine saturation isotherms and IC~0 and Ki for glycine, I~-alanine, and taurine displacement of bound [3H]strychnine were estimated using the InPIot program (Graph Pad Software, San Diego, CA).
